Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Re-engineering a Killer Virus
To assess the risk posed by a virus that could acquire all eight of the 1918-like killer influenza genes, researchers at the University of Wisconsin used reverse genetics techniques to generate a virus that differed from the 1918 virus by only 3% of the amino acids that make up the virus proteins. A number of scientists have questioned the sanity of carrying out such an experiment on a microbe with the potential to cause a deadly worldwide pandemic.